Muscular Dystrophy Association and Friedreich’s Ataxia Research Alliance Announce Collaborative Research Grant Using Novel Gene Editing Technology to Address Root Cause of Friedreich’s Ataxia Disease
April 17, 2024 09:00 ET
|
Muscular Dystrophy Association
New York, April 17, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) and Friedreich’s Ataxia Research Alliance (FARA) announced today a collaborative grant for $300,000 awarded to...
New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment Outcomes
April 17, 2024 08:00 ET
|
Genetic Technologies Ltd
New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment Outcomes
Kamari Pharma Announces Abstracts Accepted for Presentation at the 81st Annual Meeting of the Society for Investigative Dermatology
April 16, 2024 16:05 ET
|
Kamari Pharma
Late breaking poster presentation includes Phase 1b clinical trial results demonstrating the safety and preliminary efficacy of KM-001, a topical TRPV3 inhibitor, for the treatment of palmoplantar...
GeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year on Year
April 16, 2024 08:00 ET
|
Genetic Technologies Ltd
GeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year on Year
GTG to pilot GeneType in Breast Screen centers across the U.S.
April 11, 2024 08:00 ET
|
Genetic Technologies Ltd
Genetic Technologies to pilot GeneType in Breast Screen centers across the U.S.
EVENT - Empowering Women Through Knowledge; Humanise Health & GeneType Launch "Know Your Risk”
April 08, 2024 08:00 ET
|
Genetic Technologies Ltd
Humanise Health & GeneType and launch "Know Your Risk" event
Bion Announces Voluntary Share Surrender
April 02, 2024 08:34 ET
|
BION ENVIRONMENTAL TECHNOLOGIES INC
New York, NY, April 02, 2024 (GLOBE NEWSWIRE) -- Bion Environmental Technologies, Inc. (OTC QB: BNET), a leader in advanced livestock waste treatment technology and premium sustainable beef,...
Genetic Technologies’ Digital Strategy Ignites Significant Traction in US Market
April 02, 2024 08:05 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, April 02, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and...
Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors
March 31, 2024 19:00 ET
|
Curative Biotechnology, Inc.
Palm Beach Gardens, FL, and Tokyo, Japan, March 31, 2024 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company...
キュレイティブ・バイオテクノロジー (Curative Biotechnology, Inc.)、テレサ・ヒー博士 (Dr. Theresa Heah) を取締役会に指名することを発表
March 31, 2024 19:00 ET
|
Curative Biotechnology, Inc.
フロリダ州パームビーチおよび東京発, April 01, 2024 (GLOBE NEWSWIRE) -- 変性眼疾患の新しい治療法に焦点を当てた開発段階の生物医学企業であるキュレイティブ・バイオテクノロジー (OTC: CUBT) (「キュレイティブ・バイオテック」または「同社」)...